A real-time interaction cytometry (RT-IC) experiment using heliXcyto biosensor was designed to reveal the impact of the improved EGFR binding kinetics on the binding kinetics of the antibody variant LCE-E and target-positive tumor cells compared to the wildtype HCP-LCE. The gene discussed is EGFR; the disease is neoplasm.